LISATA THERAPEUTICS, INC. Cash Equivalents, at Carrying Value
LISATA THERAPEUTICS, INC. (LSTA) had Cash Equivalents, at Carrying Value of $14.49 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2025-11-06
- 2025-09-30: Cash Equivalents, at Carrying Value $14.49M.
- 2025-06-30: Cash Equivalents, at Carrying Value $12.12M.
- 2025-03-31: Cash Equivalents, at Carrying Value $17.37M.
- 2024-12-31: Cash Equivalents, at Carrying Value $10.61M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-09-30 | $14.49M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $12.12M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $17.37M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $10.61M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $13.95M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $23.86M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $17.68M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $16.71M 10-K · filed 2025-02-27 |
| 2023-09-30 | $29.10M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $19.48M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $22.64M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $27.67M 10-Q · filed 2023-11-02 |
| 2022-09-30 | $23.28M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $30.05M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $10.65M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $21.13M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $9.60M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $9.05M 10-Q · filed 2021-08-05 |
| 2020-12-31 | $12.68M 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |